Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00727649 · ClinicalTrials.gov registry record · Phase 2
Efficacy and Mechanisms of Pharmacologic Treatment of Fecal Incontinence
A Phase 2 study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 2
- Development phase
- 80
- Enrollment target
NCT00727649: Completed Phase 2 study, sponsored by US Department of Veterans Affairs.
NCT00727649 is a Phase 2 study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 80 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (40% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00727649, a Phase 2 study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 80 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate and compare treatment with fiber and loperamide for fecal incontinence.
Primary Outcome
After consent, 7-day bowel diary was assessed at baseline (2-week visit), during the last week of the 4-week intervention (6-week visit), during the second week of the 2-week wash-out period at 8-weeks, and during the last week of the second 4-week intervention (12 weeks). The mean number of total fecal incontinence episodes from a 7-day bowel diary from each time point was compared between the groups.
Interventions
- DRUG Loperamide
- DRUG Psyllium powder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2008-07 |
| Est. Completion | 2013-12 |
| Phase | Phase 2 |
What the finished NCT00727649 record still lists
NCT00727649 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (40% lower).
The record links to 0 conditions, and to 2 interventions - of which Loperamide is the first listed.
NCT00727649 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00727649 about?
NCT00727649 is a clinical study titled "Efficacy and Mechanisms of Pharmacologic Treatment of Fecal Incontinence". The purpose of this study is to evaluate and compare treatment with fiber and loperamide for fecal incontinence.
What is the current status of trial NCT00727649?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 80 participants. The study started on 2008-07. Estimated completion is 2013-12.
What interventions are being tested in trial NCT00727649?
The interventions under investigation include: Loperamide (DRUG), Psyllium powder (DRUG).
Who is sponsoring clinical trial NCT00727649?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00727649's enrollment target sits among peer trials
80 842nd of 2000 higher than 1,117 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia